The grant, which would have benefitted the Birmingham Biotechnology Hub, led by Southern Research, has been cancelled. The ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

Biotechnology company Regeneron Pharmaceuticals ... notably spanning from a 2023 data breach - along with questions around what new ownership could mean for users' data. RELATED: 23andMe ...

Bharat Biotech’s oral cholera vaccine, Hillchol, aims to ease a critical global shortfall, with the world currently lacking ...

Following a regulatory setback last year, Satsuma Pharmaceuticals Inc. has won approval for its nasal powder migraine ...

Alicia Alford, a recent graduate of the BULLS Life Sciences Academy and Durham Technical Community College, said Accelerate NC had helped her get her new “big girl job” as a Manufacturing Associate I ...

In March, 23andMe said that it was looking to sell “substantially all of its assets” through a court-approved reorganization plan.

Biotechnology company Regeneron Pharmaceuticals ... notably spanning from a 2023 data breach — along with questions around what new ownership could mean for users’ data. US spring homebuying ...

Old royalty assumptions Several simple ... consider your profitability as a measure of success. New royalty approaches Pharmaceutical and biotechnology companies today use varying techniques ...